Navigation Links
World Congress on Industrial Biotechnology: Germany Home to Top Biotech Research and Investment
Date:4/25/2008

BERLIN, April 25 /PRNewswire/ -- Processes and products based on biomass and industrial biotechnology offer significant business potential for the chemical industry in a wide range of applications such as bioplastics. A panel on developments in the field of industrial biotechnology in Germany will be held at the World Congress on Industrial Biotechnology and Bioprocessing (April 27-30, 2008) in Chicago, Illinois. The panel runs from 10:45am to 12:15pm on April 28th at the Hilton Chicago, 720 South Michigan Ave.

Research institutes play a pivotal role in biotechnology investments, and they are particularly strong in Germany as the country has many internationally recognized research centers. Dr. Steffen Rupp is the Head of Molecular Biotechnology of Fraunhofer IGB at the Fraunhofer Campus Stuttgart. His laboratory is a part of the wider network of Fraunhofer Institutes, a world-renowned research organization with affiliate centers all over Germany. He will discuss renewable feedstock such as residual biomass and ways of transforming such biomass into practical energy sources.

Chemical parks are a major attraction to Germany for the chemicals and biotechnology industries. Dr. Markus Wolperdinger is in charge of industrial biotech activities at InfraLeuna GmbH. InfraLeuna is the owner and infrastructure provider of one of Germany's largest chemical sites. The Leuna chemical site is home to over 100 companies, including some of the world's top chemical companies. Dr. Wolperdinger will discuss activities in the industrial biotechnology field that are currently taking place at the Leuna chemical site.

Dr. Karin Bronnenmeier will discuss the transfer of knowledge from fossil based refineries to future biorefineries. Specifically the integration of biotech expertise from biopharma biotech will be the focus of her presentation. She is the "know-how" manager for Biotechnology Plants at Linde-KCA-Dresden, the Competence Center Biotechnology at Linde
'/>"/>

SOURCE Invest in Germany
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in Sirtuin Research and Development
2. febit to Introduce Geniom RT Analyzer(R) to U.S. Market at RNAi World Congress
3. Novavax CEO to Present at the World Vaccine Congress 2008
4. BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance
5. Graphene used to create worlds smallest transistor
6. BioSpace and IBC Life Sciences Announce Career Fair Alliance For Drug Discovery & Development of Innovative Therapeutics World Congress
7. Researchers create the first thermal nanomotor in the world
8. WorldHeart 10-KSB Audit Report Includes Going Concern Qualification
9. Real-World Data from ARRIVE Registries Show Favorable Outcomes for TAXUS(R) Express(TM) Stent
10. CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide
11. Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 Crystal Diagnostics (CDx) ... that it has received AOAC-PTM Certifications for the six non-O157 ... and O145; collectively referred to as STEC or the “Big-6”) ... colony forming unit (cfu) per 325 g of raw ground ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 zFlo Motion ... pleased to announce an exciting product from a new partner. ... analysis solutions over the past 15 years, with offerings in ... recently, their 3D IMU system (inertial measurement unit), iSen, is ...
(Date:1/22/2015)... Controlled Substance Compliance Services (CSCS), a project managed ... legal requirements around using controlled substances in pharmaceutical research, ... their international operations expand and become increasingly complex, large ... a result of the first phase of the CSCS ...
(Date:1/22/2015)... 2015 Diagenode, Inc., a leading ... Bioruptor® and complete solutions for epigenetics research, recently ... alleviating the need for manual processing. The new ... ChIP of histones or transcription factors and a ...
Breaking Biology Technology:Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 23D Motion Capture Just Got Easy 2Global Compliance Service for Controlled Substances to Expand to China 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2
... by allowing for diversity of research,approaches while also encouraging sharing of IP, ... ... to result from reduced complexity, elimination of ... be maintained; South San Francisco,site to operate as an independent research and ...
... ev3 Inc. (Nasdaq:,EVVV) will release its 2008 second quarter ... regular market trading hours., The company will host ... a.m. Central Time (8:30 a.m. Eastern Time). ev3 management ... followed by a,question and answer session., The conference ...
... Apo-Al/HDL drug to be highlighted, TSX Exchange ... Resverlogix Corp.,("Resverlogix" or the "Company") (TSX:RVX) is pleased ... in an article titled,"Emerging Antidyslipidemic Drugs", which appears ... Drugs, a well respected scientific journal for,the pharmaceutical ...
Cached Biology Technology:Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 2Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 3Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 4Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 5Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 6Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 7Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 8Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 9Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 10Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 11Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 12ev3 Inc. to Report 2008 Second Quarter Financial Results and Host Conference Call on August 1, 2008 2Resverlogix's Lead Drug Featured in Key Scientific Publication 2
(Date:1/22/2015)... 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is ... the State of Washington,s Department of ... enrollment and central issuance system for driver,s licenses and identification ... project planning and development will start in January 2015, with ...
(Date:1/22/2015)... N.C. , Jan. 16, 2015  A man-made form ... memory and other mental capabilities in adults with mild ... pilot study led by researchers at Wake Forest Baptist ... adults diagnosed with amnesic mild cognitive impairment (MCI) or ...
(Date:1/22/2015)... and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ) has ... Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, ... report to their offering. , ... be worn on the user,s body and have ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
... The Wistar Institute shows how our cells create alternate versions ... genes are associated with multiple gene promoters, the researchers say, ... gene, for example, can be made with the same genetic ... Research, available online now, show how genes are read in ...
... Networks of biologically-connected marine protected areas need to be ... of marine fish larvae that take them from one ... Research published today in the international journal Oecologia sheds ... their larval stages, important information for the effective design ...
... American Association for Cancer Research has been the premier ... This year, Elizabeth H. Blackburn, Ph.D., the immediate ... laureate, will chair the Second AACR Conference on Frontiers ... research leaders from across the globe to encourage and ...
Cached Biology News:Multiple 'siblings' from every gene: Alternate gene reading leads to alternate gene products 2Multiple 'siblings' from every gene: Alternate gene reading leads to alternate gene products 3Data revealing migrations of larval reef fish vital for designing networks of marine protected areas 2
TEMPLIPHI HT SEQ AMPL KIT, 1 EA. Category: Sequencing Template Amplification....
... Vybrant Apoptosis Assay Kit #4 ... that occur in the permeability of cell ... both YO-PRO-1 and propidium iodide nucleic acid ... plasma membranes of apoptotic cells and labels ...
Request Info...
5-bromo-4-chloro-3-indolyl b -D-galactopyranoside (X-Gal)...
Biology Products: